Fisher, Simon J.
Huang, Xingyue
Pawaskar, Manjiri
Witt, Edward A.
Rajpathak, Swapnil
Shankar, R. Ravi
Inzucchi, Silvio E.
Funding for this research was provided by:
Merck
Article History
Received: 28 November 2017
Accepted: 21 January 2018
First Online: 19 February 2018
Compliance with ethical standards
:
: Dr. Inzucchi has served as a consultant to Janssen, Lexicon, Sanofi, and vTv Therapeutics; has severed on clinical trial steering or executive committees for AstraZeneca, Boehringer Ingelheim, Novo Nordisk, and Daiichi Sankyo; and has participated as a member of a data monitoring committee for Intarcia. Dr. Fisher has served as a consultant for Merck & Co., Inc., Kenilworth, NJ, USA and NovoNordisk. M.P., S.R., R.R.S. are employees and stockholders of Merck & Co., Inc., Kenilworth, NJ, USA. E.W. was employee of Kantar Health when work was completed. X.H. was an employee of Merck & Co., Inc., Kenilworth, NJ, USA at the time when study was conducted.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.